TransCode Therapeutics Inc. (RNAZ) - Utang marang Ekuitas

Lambang korporat lan logo TransCode Therapeutics Inc. (RNAZ)

The key risk for TransCode Therapeutics (RNAZ) remains the precision of drug delivery to tumor tissues and their stability within the body. This price chart reflecting trading dynamics shows that the individual debt-to-equity ratio is 0.00. TransCode Therapeutics (RNAZ) complies with environmental standards for biomaterial recycling, and its business model relies on proprietary drug delivery methods that ensure high margins during global production scaling.

RNAZ: Total Utang marang Modal TransCode Therapeutics 04.07.2022 - 26.10.2026

Rincian analitis lan laporan data perusahaan TransCode Therapeutics, Inc. (RNAZ)

- rega lan prakiraan konsensus rega:
Rega saham TransCode Therapeutics Inc.|RNAZ - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Nilai pasar TransCode Therapeutics|RNAZ - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham TransCode Therapeutics|RNAZ - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih transcodetherapeutics.com|RNAZ - Aset Agregat Bisnis
- data utang lan likuiditas:
Utang marang Ekuitas TransCode Therapeutics|RNAZ - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal TransCode Therapeutics Inc.|RNAZ - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku TransCode Therapeutics
Ringkesan analisis perusahaan:RNAZ TransCode Therapeutics
Produk seri TransCode Therapeutics, Inc.

For TransCode Therapeutics (RNAZ), which develops targeted RNA therapeutics through scientific partnerships, this indicator assesses the sustainability of its innovation financing structure. By analyzing the current debt-to-equity ratio, an investor compares total liabilities against net assets to determine the business's level of dependence on borrowed funds and the risk of the asset becoming a value trap in the event of uncontrolled debt growth.

Pesaing wigati

Total Utang marang Modal tempus.com (TEM)|Rasio Utang marang Ekuitas QGEN|Utang marang Ekuitas Ionis Pharma IONS|Rasio Utang marang Ekuitas Repligen Inc. (RGEN)|Total Utang marang Modal RNA (Avidity Biosciences)|CRSP - Total Utang marang Modal|Rasio Total Utang marang Ekuitas GeneDx WGS|RARE: Utang Agregat marang Modal|Utang marang Ekuitas Beam Therapeutics Corp BEAM|Sarepta Corp (SRPT) - Rasio Kabeh Utang marang Dana Pribadi|TWST (Twist Bioscience) - Total Utang marang Modal|Total Utang marang Modal TXG|Utang marang Ekuitas Intellia Therapeutics, Inc. NTLA|Rasio Utang marang Ekuitas STOK (Stoke Therapeutics Inc)|Utang marang Ekuitas BLFS|Koefisien Total Utang marang Modal Wave Pharma WVE|MAZE: Total Utang marang Modal|SION: Rasio Total Utang marang Ekuitas|Utang marang Ekuitas PRME|Taysha Gene Therapies Inc (TSHA) - Utang marang Modal|Total Utang marang Modal uniQure Corp (QURE)|Rasio Utang marang Ekuitas MeiraGTx Corp|REGENXBIO Inc. - Total Utang marang Modal|Utang marang Modal solidbio.com SLDB|Rasio Total Utang marang Ekuitas Ocugen|PACB - Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas Benitec BNTC|DSGN - Utang Agregat marang Modal|Total Utang marang Modal Rocket Pharmaceuticals RCKT|4dmoleculartherapeutics.com (FDMT) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LXEO (Lexeo Therapeutics Inc.)|Utang marang Modal KRRO|Editas (EDIT) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Silence Therapeutics Corp (SLN)|Total Utang marang Modal PRQR (ProQR Therapeutics)|Codexis Inc - Total Utang marang Modal|Utang marang Ekuitas Sangamo Therapeutics, Inc.|NAUT - Utang Agregat marang Ekuitas|Total Utang marang Modal MGX|Utang marang Modal Precision BioSciences Inc.|GBIO (Generation Bio Co) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal boundlessbio.com (BOLD)|Rasio Total Utang marang Ekuitas Exicure, Inc.|Utang Agregat marang Modal imunon.com (IMNN)|Total Utang marang Modal PHIO|Koefisien Total Utang marang Modal Mustang Bio Inc MBIO|BNGO: Total Utang marang Modal|APDN: Rasio Total Utang marang Ekuitas|bluebird bio - Utang marang Ekuitas|IPA (ImmunoPrecise Antibodies Ltd.) - Koefisien Total Utang marang Modal|OMGA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi OMIC|Utang marang Ekuitas Regulus Therapeutics RGLS|Rasio Utang marang Ekuitas syros.com (SYRS)|Total Utang marang Modal TBIO (Telesis Bio)|TCON - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Unity Bio